Navigation Links
Schaerer Axis 800

ProductsSchaerer Axis 800
Company Schaerer Mayfield USA, Inc.
Item Schaerer Axis 800
Features SAFETY AND FUNCTIONALITY
Two independently working operating systems possessing the same function are built into the table base and can be run separately. One system is controlled via the Hand Control, while the other system is controlled by means of the Override-Panel. This allows for highest operating safety and eliminates the risk of system failure.

PATIENT POSITIONING
The 190° motor-driven articulated joint permits excellent adjustment possibilities for sitting and half-sitting positions.

MOBILITY
Three swiveling double castors with a diameter of 120mm facilitate table mobility, even in the tightest spaces. For effortless movement of the table in Basic or Reverse position, the swiveling castors can be locked in place with the foot pedal. The operating table can thus be steered by one person alone.

EASY OPERATION
The ergonomic form of the Hand Control, its well-arranged keyboard and the LCD-Display for all important functions make using the schaerer axis 800 easier and safe
Description The schaerer axis 800 operating table has been specially designed for those disciplines which require maximum C-arm access. The stability, the electrohydraulic adjustment possibilities and the offset positioned telescoping column ensure universal use to cover all surgical disciplines.
Info Schaerer Mayfield USA, Inc.
Customer Service: (800) 755-6381
Web site: http://www.schaerermayfieldusa.com

Related medicine products :

1. Schaerer Arcus 500-700
2. Schaerer Axis 400-700
3. Schaerer Axis 200/300
... Ultrapure MB Grade PRODUCT SPECIFICATIONS Form: Granular, free flowing ... to 0.12 Gel Point (3%): less than or ... or equal to 76C Gel Strength (3%): greater than ... (5%): greater than or equal to 1000 gm/cm 2 ...
... Ultrapure MB Grade PRODUCT SPECIFICATIONS Form: Granular, free-flowing ... to 0.12 Gel Point (3%): less than or ... or equal to 80C Gel Strength (1.5%): greater ... Gel Strength (3%): greater than or equal to ...
... ≤ 5000 mg/kg sulfate (SO 4 ) ≤ 5000 ... 5 mg/kg Co ≤ 5 mg/kg Cr ≤ 5 ... K ≤ 50 mg/kg Mg ≤ 5 mg/kg Mn ... 5 mg/kg Pb ≤ 5 mg/kg Zn ≤ 5 ...
... (Cl) ≤ 500 mg/kg sulfate (SO 4 ) ≤ ... ≤ 5 mg/kg Co ≤ 5 mg/kg Cr ≤ ... mg/kg K ≤ 5 mg/kg Mg ≤ 5 mg/kg ... ≤ 5 mg/kg Pb ≤ 5 mg/kg Zn ≤ ...
Medicine Products:
(Date:12/7/2016)... Hamden, CT (PRWEB) , ... December 07, 2016 , ... ... has prompted an outpouring of comments on social media that offer a rare glimpse ... adult psychiatrist, leading ADHD authority and New York Times bestselling author, has described people ...
(Date:12/7/2016)... ... 2016 , ... They are musicians and librarians, fashion designers and fitness instructors, ... New England and around the nation. What do they have in common? All have ... beautiful and compelling new photographic exhibit debuting Friday, December 9 at Logan International Airport ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... is now promoting to the US market its advanced highly customizable contact technology ... and ODU TURNTAC®. These advanced technologies are ideal for a wide range of ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... consultation services to residents in the Sacramento/Folsom region, is initiating a charity event ... , The Another Choice Another Chance treatment center in Sacramento works to provide ...
(Date:12/7/2016)... PA (PRWEB) , ... December 07, 2016 , ... One ... regular changing of the securement tape is painful for her. "This is why the ... to patients’ heads," she said. , They then created a prototype of the patent-pending ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... VILLAGE, Calif. , Dec. 6, 2016 ... privately held, clinical-stage medical dermatology and aesthetics ... plc, a privately held specialty pharmaceutical company ... common inflammatory skin conditions, including psoriasis, atopic ... of the agreement, Sienna will make an ...
(Date:12/6/2016)... , Dec. 6, 2016  Arcturus Therapeutics, Inc. ... company, announced today that it entered into collaboration ... therapeutics for the treatment of NASH and other ... delivery platform LUNAR™ and UNA Oligomer chemistry. The ... Takeda,s long-standing commitment to and expertise in GI ...
(Date:12/6/2016)... , Dec. 6, 2016  Regulus Therapeutics Inc. ... leading the discovery and development of innovative medicines ... candidates at its R&D day, held in ... RGLS5040, is an anti-miR targeting microRNA-27 (miR-27) for ... RGLS4326, is an anti-miR targeting microRNA-17 (miR-17) for ...
Breaking Medicine Technology: